HYPD - EYENOVIA, INC.
3.11
0.010 0.322%
Share volume: 79,782
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.10
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-12-2024 | 05-19-2025 | 08-13-2025 | 11-14-2025 | |
| Total revenue | 4.993 K | 22.625 K | 1.625 K | 14.720 K | 0.000 | 302.506 K | |
| Cost of revenue | 4.993 K | 490.361 K | 132.522 K | 48.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | -467.736 K | -130.897 K | 14.672 K | 0.000 | 302.506 K | |
| inf% | 72.01% | 111.21% | -100.00% | inf% | |||
| Operating expenses | 8.267 M | 8.356 M | 7.201 M | 3.045 M | 8.353 M | 2.968 M | |
| Selling general and admin | 3.835 M | 3.759 M | 3.729 M | 2.372 M | 7.679 M | 2.594 M | |
| Research and development | 4.432 M | 4.597 M | 3.472 M | 673.043 K | 674.578 K | 373.855 K | |
| Total expenses | 10.267 M | 11.221 M | 7.201 M | 3.045 M | 8.353 M | -4.126 M | |
| 9.29% | -35.82% | -57.71% | 174.29% | -149.39% | |||
| Operating income | -10.267 M | -11.688 M | -7.332 M | -3.031 M | -8.353 M | 4.428 M | |
| Ebit | -10.364 M | -10.445 M | -7.331 M | -3.027 M | -8.184 M | 6.805 M | |
| Pretax income | -10.922 M | -11.054 M | -7.888 M | -3.484 M | -8.691 M | 6.626 M | |
| 1.20% | -28.64% | -55.84% | 149.49% | -176.24% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -10.922 M | -11.054 M | -7.888 M | -3.484 M | -8.691 M | 6.626 M | |
| -1.20% | 28.64% | 55.84% | -149.49% | 176.24% |